New research published in the British Journal of Nutrition suggests intermittent energy restriction diets clear fat from the blood more efficiently after a meal than regular calorie restrictive diets. They also saw a larger decrease in systolic blood pressure compared to the control, which can reduce risk for cardiovascular disease (CVD).

The racial gap for cardiovascular health in America is narrowing, but the news isn’t as encouraging as it initially sounds. The disparity is shrinking because decreasing overall health in whites, not because of gains made by minority groups.

War injuries and subsequent post-traumatic stress disorder (PTSD) have been found to double the risk for high blood pressure, according to a new study published in Hypertension on March 19.

Linda Gates-Striby raised some eyebrows at the American College of Cardiology’s Cardiovascular Summit in February when, in one PowerPoint slide, she showed how much proper documentation and coding could affect a hospital’s quality measures, bottom line—and even a doctor’s reputation.

Girls who enter puberty earlier have an increased risk of obesity as they get older, according to research published online Feb. 6 in the International Journal of Obesity.

Higher alcohol consumption was linked to faster and faster heart rates in a study of more than 3,000 people attending the Munich Oktoberfest.

DUBLIN and BARCELONA, Spain - MARCH 19, 2018 - Medtronic plc (NYSE: MDT) today announced one-year results from the CRYO4PERSISTENT AF study of ablation with the Arctic Front Advance(TM) Cryoballoon to isolate the pulmonary veins in patients with symptomatic persistent atrial fibrillation (AF).

ABBOTT PARK, Ill., March 19, 2018 — Abbott today announced that the Ministry of Health Labour and Welfare (MHLW) in Japan granted national reimbursement for the company's MitraClip therapy to treat people with mitral regurgitation, a serious, progressive heart disease in which the mitral valve does not close properly, allowing blood to flow backward into the heart.

One college dean is taking a new approach to attracting diverse talent to medical schools and fellowships across the country, and it’s one that involves taking a hard look at established prejudices and recognizing directors’ own biases.

Canagliflozin reduced the risk of death or hospitalization for heart failure by 22 percent among patients with type 2 diabetes and a high risk of cardiovascular disease, according to results of the CANVAS trial presented March 11 at the American College of Cardiology’s scientific session and published simultaneously in Circulation.